Document is current
Any future updates will be listed below
-
Authors
Williams, Ella https://orcid.org/0000-0002-8159-7704
Taujanskaite, Ursule
Kamboj, Sunjeev K. https://orcid.org/0000-0003-2197-0826
Murphy, Susannah E. https://orcid.org/0000-0001-8995-2099
Harmer, Catherine J. https://orcid.org/0000-0002-1609-8335
-
Funding
Funding for this research was provided by:
NIHR Oxford Health Biomedical Research Centre
- License Information
-
More Information
Article History
Received: 11 September 2024
Revised: 13 December 2024
Accepted: 26 December 2024
First Online: 17 January 2025
Competing interests
: SEM has received consultancy fees from Zogenix, Sumitomo Dainippon Pharma, UCB Pharma and Janssen Pharmaceuticals. SEM holds grant income from Janssen Pharmaceuticals. CJH has received consultancy fees from Zogenix, IESO, UCB Pharma, P1vital, Lundbeck, and Janssen Pharmaceuticals. The remaining authors have nothing to disclose.
